04:14 PM EDT, 09/11/2025 (MT Newswires) -- Kestra Medical Technologies ( KMTS ) late Thursday reported a fiscal Q1 net loss of $0.50 per diluted share, narrowing from a loss of $1.12 a year earlier.

Analysts expected a loss of $0.61 in a FactSet poll.

Revenue for the quarter ended July 31 was $19.4 million, up from $12.8 million a year earlier.

Analysts expected $17.9 million.

For fiscal 2026, Kestra raised its revenue guidance to $88 million from $85 million previously. Analysts expected $85.1 million.

Shares were up more than 8% in after-hours trading.